vs

Side-by-side financial comparison of NETSCOUT SYSTEMS INC (NTCT) and Oncology Institute, Inc. (TOI). Click either name above to swap in a different company.

NETSCOUT SYSTEMS INC is the larger business by last-quarter revenue ($250.7M vs $142.0M, roughly 1.8× Oncology Institute, Inc.). NETSCOUT SYSTEMS INC runs the higher net margin — 22.0% vs -5.3%, a 27.3% gap on every dollar of revenue. On growth, Oncology Institute, Inc. posted the faster year-over-year revenue change (41.6% vs -0.5%). NETSCOUT SYSTEMS INC produced more free cash flow last quarter ($59.3M vs $2.2M). Over the past eight quarters, Oncology Institute, Inc.'s revenue compounded faster (22.5% CAGR vs 11.0%).

NETSCOUT Systems, Inc. is an American technology company that specializes in software observability, deep packet inspection, DDoS mitigation and AIOps. Headquartered in Westford, Massachusetts, the company was founded in 1984 by Anil Singhal and Narendra Popat, originally under the name Frontier Software.

Oncology Institute, Inc. is a specialized healthcare enterprise focused on delivering patient-centric, evidence-based oncology care services, including advanced treatment regimens, clinical trial access, and supportive care programs. It primarily operates across the United States, serving patients with diverse cancer diagnoses and partnering with care teams to improve treatment outcomes.

NTCT vs TOI — Head-to-Head

Bigger by revenue
NTCT
NTCT
1.8× larger
NTCT
$250.7M
$142.0M
TOI
Growing faster (revenue YoY)
TOI
TOI
+42.1% gap
TOI
41.6%
-0.5%
NTCT
Higher net margin
NTCT
NTCT
27.3% more per $
NTCT
22.0%
-5.3%
TOI
More free cash flow
NTCT
NTCT
$57.1M more FCF
NTCT
$59.3M
$2.2M
TOI
Faster 2-yr revenue CAGR
TOI
TOI
Annualised
TOI
22.5%
11.0%
NTCT

Income Statement — Q3 FY2026 vs Q4 FY2025

Metric
NTCT
NTCT
TOI
TOI
Revenue
$250.7M
$142.0M
Net Profit
$55.1M
$-7.5M
Gross Margin
81.6%
Operating Margin
25.7%
-4.9%
Net Margin
22.0%
-5.3%
Revenue YoY
-0.5%
41.6%
Net Profit YoY
13.0%
43.0%
EPS (diluted)
$0.75
$-0.04

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
NTCT
NTCT
TOI
TOI
Q4 25
$250.7M
$142.0M
Q3 25
$219.0M
$136.6M
Q2 25
$186.7M
$119.8M
Q1 25
$205.0M
$104.4M
Q4 24
$252.0M
$100.3M
Q3 24
$191.1M
$99.9M
Q2 24
$174.6M
$98.6M
Q1 24
$203.4M
$94.7M
Net Profit
NTCT
NTCT
TOI
TOI
Q4 25
$55.1M
$-7.5M
Q3 25
$25.8M
$-16.5M
Q2 25
$-3.7M
$-17.0M
Q1 25
$18.6M
$-19.6M
Q4 24
$48.8M
$-13.2M
Q3 24
$9.0M
$-16.1M
Q2 24
$-443.4M
$-15.5M
Q1 24
$-32.4M
$-19.9M
Gross Margin
NTCT
NTCT
TOI
TOI
Q4 25
81.6%
Q3 25
80.1%
Q2 25
76.7%
Q1 25
77.7%
Q4 24
81.5%
Q3 24
78.0%
Q2 24
74.6%
Q1 24
75.3%
Operating Margin
NTCT
NTCT
TOI
TOI
Q4 25
25.7%
-4.9%
Q3 25
14.8%
-5.9%
Q2 25
-3.5%
-9.4%
Q1 25
9.7%
-9.5%
Q4 24
24.5%
-11.9%
Q3 24
7.4%
-13.9%
Q2 24
-265.4%
-16.6%
Q1 24
-18.2%
-19.0%
Net Margin
NTCT
NTCT
TOI
TOI
Q4 25
22.0%
-5.3%
Q3 25
11.8%
-12.1%
Q2 25
-2.0%
-14.2%
Q1 25
9.1%
-18.8%
Q4 24
19.4%
-13.1%
Q3 24
4.7%
-16.1%
Q2 24
-254.0%
-15.7%
Q1 24
-15.9%
-21.0%
EPS (diluted)
NTCT
NTCT
TOI
TOI
Q4 25
$0.75
$-0.04
Q3 25
$0.35
$-0.14
Q2 25
$-0.05
$-0.15
Q1 25
$0.28
$-0.21
Q4 24
$0.67
$-0.14
Q3 24
$0.13
$-0.18
Q2 24
$-6.20
$-0.17
Q1 24
$-0.43
$-0.22

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
NTCT
NTCT
TOI
TOI
Cash + ST InvestmentsLiquidity on hand
$540.6M
Total DebtLower is stronger
Stockholders' EquityBook value
$1.6B
$-15.7M
Total Assets
$2.3B
$164.7M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
NTCT
NTCT
TOI
TOI
Q4 25
$540.6M
Q3 25
$483.4M
Q2 25
$489.6M
Q1 25
$457.4M
Q4 24
$398.4M
Q3 24
$363.4M
Q2 24
$362.2M
$9.9M
Q1 24
$389.7M
$29.8M
Stockholders' Equity
NTCT
NTCT
TOI
TOI
Q4 25
$1.6B
$-15.7M
Q3 25
$1.6B
$-12.3M
Q2 25
$1.5B
$-9.0M
Q1 25
$1.6B
$5.1M
Q4 24
$1.5B
$3.6M
Q3 24
$1.5B
$15.5M
Q2 24
$1.4B
$29.2M
Q1 24
$1.9B
$41.3M
Total Assets
NTCT
NTCT
TOI
TOI
Q4 25
$2.3B
$164.7M
Q3 25
$2.2B
$163.6M
Q2 25
$2.2B
$159.8M
Q1 25
$2.2B
$164.0M
Q4 24
$2.2B
$172.7M
Q3 24
$2.1B
$179.2M
Q2 24
$2.1B
$179.6M
Q1 24
$2.6B
$204.5M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
NTCT
NTCT
TOI
TOI
Operating Cash FlowLast quarter
$62.1M
$3.2M
Free Cash FlowOCF − Capex
$59.3M
$2.2M
FCF MarginFCF / Revenue
23.6%
1.5%
Capex IntensityCapex / Revenue
1.1%
0.7%
Cash ConversionOCF / Net Profit
1.13×
TTM Free Cash FlowTrailing 4 quarters
$275.5M
$-27.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
NTCT
NTCT
TOI
TOI
Q4 25
$62.1M
$3.2M
Q3 25
$6.7M
$-12.6M
Q2 25
$73.6M
$-10.2M
Q1 25
$141.5M
$-5.0M
Q4 24
$41.5M
$4.2M
Q3 24
$-3.7M
$819.0K
Q2 24
$38.4M
$-15.7M
Q1 24
$93.6M
$-15.9M
Free Cash Flow
NTCT
NTCT
TOI
TOI
Q4 25
$59.3M
$2.2M
Q3 25
$4.4M
$-13.2M
Q2 25
$71.7M
$-11.4M
Q1 25
$140.1M
$-5.3M
Q4 24
$39.6M
$2.4M
Q3 24
$-4.6M
$417.0K
Q2 24
$37.2M
$-17.5M
Q1 24
$92.0M
$-16.5M
FCF Margin
NTCT
NTCT
TOI
TOI
Q4 25
23.6%
1.5%
Q3 25
2.0%
-9.7%
Q2 25
38.4%
-9.5%
Q1 25
68.4%
-5.1%
Q4 24
15.7%
2.4%
Q3 24
-2.4%
0.4%
Q2 24
21.3%
-17.7%
Q1 24
45.2%
-17.4%
Capex Intensity
NTCT
NTCT
TOI
TOI
Q4 25
1.1%
0.7%
Q3 25
1.0%
0.4%
Q2 25
1.0%
1.0%
Q1 25
0.7%
0.3%
Q4 24
0.7%
1.8%
Q3 24
0.5%
0.4%
Q2 24
0.7%
1.9%
Q1 24
0.8%
0.6%
Cash Conversion
NTCT
NTCT
TOI
TOI
Q4 25
1.13×
Q3 25
0.26×
Q2 25
Q1 25
7.60×
Q4 24
0.85×
Q3 24
-0.41×
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

NTCT
NTCT

Services$129.0M51%
Products$121.7M49%

TOI
TOI

Other$82.1M58%
Fee For Service$36.3M26%
Capitated Revenue$23.6M17%

Related Comparisons